皇冠官网app

皇冠登录网址

Our medicines are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. In some cases, health care professionals and patients can visit local AstraZeneca websites to find out more about our medicines. Please note that in some countries we are not allowed to provide very much, or sometimes any, information on our prescription medicines so you should seek alternative trustworthy sources. Always ask a healthcare professional for advice about medicines.皇冠官网app



皇冠登录网址

The safety of our patients is very important to us. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

By reporting any side effects that you may experience, you are helping to provide 更多 资讯rmation on the safety of our medicines. Report a possible side-effect to AstraZeneca by 'report side-effect' below. If you are based in the UK, you can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.



Cardiovascular, Renal and Metabolic Diseases皇冠官网app

Please note that the 产品介绍s mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific 资讯rmation is available from your local AstraZeneca company.

 

Atacand, Atacand HCT, Atacand Plus皇冠官网app

candesartan cilexetil

Brilinta/Brilique皇冠官网app

ticagrelor

Bydureon皇冠官网app

exenatide

Byetta皇冠官网app

exenatide injection

Crestor皇冠官网app

rosuvastatin

Farxiga/Forxiga皇冠官网app

dapagliflozin

Komboglyze皇冠官网app

saxagliptin and metformin HCl

Kombiglyze XR皇冠官网app

saxagliptin and metformin XR

Lokelma皇冠官网app

Sodium zirconium cyclosilicate

Onglyza皇冠官网app

saxagliptin

Plendil, Modip, Splendil, Munobal, Flodil 皇冠官网app

felodipine

Qtern皇冠官网app

dapagliflozin and saxagliptin

Seloken ZOK, Toprol-XL, Betaloc ZOK皇冠官网app

metoprolol succinate

Symlin皇冠官网app

pramlintide acetate

Tenormin, Tenormine, Prenormine, Atenol 皇冠官网app

atenolol

XIGDUO皇冠官网app

dapagliflozin and metformin HCI

XIGDUO XR 皇冠官网app

dapagliflozin and metformin HCI extended-release

Zestril皇冠官网app

lisinopril dihydrate

Oncology皇冠官网app

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Arimidex 皇冠官网app

anastrozole

Calquence皇冠官网app

acalabrutinib

Casodex, Cosudex皇冠官网app

bicalutamide

Enhertu皇冠官网app

trastuzumab deruxtecan

Faslodex 皇冠官网app

fulvestrant

Imfinzi皇冠官网app

durvalumab

Iressa皇冠官网app

gefitinib

Lynparza皇冠官网app

olaparib

Tagrisso皇冠官网app

osimertinib

Zoladex皇冠官网app

goserelin acetate implant

Infection and Vaccines皇冠官网app

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Synagis 皇冠官网app

palivizumab

Fluenz Tetra/FluMist Quadrivalent皇冠官网app

influenza vaccine live, intra-nasal

Neuroscience皇冠官网app

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Diprivan皇冠官网app

propofol

EMLA皇冠官网app

EMLA

Movantik/Moventig 皇冠官网app

naloxegol

Naropin皇冠官网app

ropivacaine

Seroquel IR皇冠官网app

quetiapine fumarate

Seroquel XR皇冠官网app

quetiapine fumarate

Xylocaine皇冠官网app

lidocaine

Zomig, Zomig Rapimelt, Zomig Nasal Spray, AscoTop, Zomigon 皇冠官网app

zolmitriptan

Respiratory皇冠官网app

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Accolate, Accoleit, Vanticon皇冠官网app

zafirlukast

Bevespi Aerosphere皇冠官网app

glycopyrronium/formoterol fumarate

Breztri Aerosphere皇冠官网app

budesonide/glycopyrronium/formoterol fumarate

Bricanyl Respules皇冠官网app

terbutaline

Bricanyl Turbuhaler皇冠官网app

terbutaline in a dry powder inhaler

Daliresp/Daxas皇冠官网app

roflumilast

Duaklir Genuair皇冠官网app

aclidinium/formoterol

Eklira Genuair/Tudorza/Bretaris皇冠官网app

aclidinium, a LAMA

Fasenra皇冠官网app

benralizumab

Oxis Turbuhaler皇冠官网app

Oxis Turbuhaler

Pulmicort Respules皇冠官网app

budesonide inhalation suspension

Pulmicort Turbuhaler皇冠官网app

budesonide

Rhinocort皇冠官网app

budesonide

Symbicort pMDI皇冠官网app

budesonide/formoterol

Symbicort Turbuhaler皇冠官网app

budesonide/formoterol

Gastrointestinal皇冠官网app

Please note that the products mentioned may not be available in all countries. Additionally, currently approved indications (uses) and presentations may differ between countries. Country specific information is available from your local AstraZeneca company.

 

Losec, Gastroloc, Mopral, Omepral, Prilosec皇冠官网app

omeprazole

Nexium皇冠官网app

esomeprazole

Vimovo皇冠官网app

naproxen and esomeprazole magnesium


皇冠登录网址

We recognise that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enrol in one of our clinical trials. In such circumstances individual patients may be eligible for early access to an AstraZeneca investigational medicinal product.

 


Veeva ID: Z4-17492    

Date of next review: 07/06/2021